These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14741060)

  • 1. A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia.
    Tuğal O; Yazici KM; Anil Yağcioğlu AE; Göğüş A
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):117-23. PubMed ID: 14741060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
    Lee BJ; Lee JG; Kim YH
    J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of low-dose donepezil in schizophrenia.
    Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA
    Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY
    Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial.
    Chung YC; Lee CR; Park TW; Yang KH; Kim KW
    World J Biol Psychiatry; 2009; 10(2):156-62. PubMed ID: 19514097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
    Keefe RS; Malhotra AK; Meltzer HY; Kane JM; Buchanan RW; Murthy A; Sovel M; Li C; Goldman R
    Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
    Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder.
    Risch SC; Horner MD; McGurk SR; Palecko S; Markowitz JS; Nahas Z; DeVane CL
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):603-5. PubMed ID: 16202177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
    Dichgans M; Markus HS; Salloway S; Verkkoniemi A; Moline M; Wang Q; Posner H; Chabriat HS
    Lancet Neurol; 2008 Apr; 7(4):310-8. PubMed ID: 18296124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
    Risch SC; Horner MD; McGurk SR; Palecko S; Markowitz JS; Nahas Z; DeVane CL
    Schizophr Res; 2007 Jul; 93(1-3):131-5. PubMed ID: 17391930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
    Stryjer R; Strous RD; Bar F; Werber E; Shaked G; Buhiri Y; Kotler M; Weizman A; Rabey JM
    Clin Neuropharmacol; 2003; 26(1):12-7. PubMed ID: 12567159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
    Friedman JI; Adler DN; Howanitz E; Harvey PD; Brenner G; Temporini H; White L; Parrella M; Davis KL
    Biol Psychiatry; 2002 Mar; 51(5):349-57. PubMed ID: 11904128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil improved memory in multiple sclerosis in a randomized clinical trial.
    Krupp LB; Christodoulou C; Melville P; Scherl WF; MacAllister WS; Elkins LE
    Neurology; 2004 Nov; 63(9):1579-85. PubMed ID: 15534239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study.
    Pérez M; Tůma I; Pytela O; Kadlecová E; Zemanová M; Lenderová Z
    Eur Psychiatry; 2006 Dec; 21(8):548-50. PubMed ID: 16797936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
    Pelton GH; Harper OL; Tabert MH; Sackeim HA; Scarmeas N; Roose SP; Devanand DP
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):670-6. PubMed ID: 18088076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia.
    Buchanan RW; Summerfelt A; Tek C; Gold J
    Schizophr Res; 2003 Jan; 59(1):29-33. PubMed ID: 12413639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.